Loading clinical trials...
Loading clinical trials...
A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination Compared to Laboratory Standard Procedures When Collected Through Peripheral Intravenous Catheters (PIVC)
Conditions
Interventions
Initial Specimen Diversion Device (ISDD)
Lab standard practice (LSP)
+1 more
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
January 1, 2014
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
August 11, 2017
NCT06650501
NCT03929159
NCT01520597
NCT05358912
NCT02689193
Lead Sponsor
Magnolia Medical Technologies, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions